Trial Profile
Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Mar 2023
Price :
$35
*
At a glance
- Drugs Diazoxide (Primary) ; Naloxone (Primary)
- Indications Diabetic complications
- Focus Pharmacodynamics
- 15 Mar 2023 Planned End Date changed from 1 Dec 2022 to 15 Dec 2023.
- 15 Mar 2023 Planned primary completion date changed from 1 Dec 2022 to 15 Dec 2023.
- 15 Mar 2023 Status changed from suspended to active, no longer recruiting.